Brief: CRISPR Therapeutics Announces Leadership Transition
Sept 7 (Reuters) - CRISPR Therapeutics AG CRSP.BN :
* CRISPR THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITION
Source text for Eikon: ID:nGNX5C64sd
Further company coverage: CRSP.BN
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crispr Therapeutics AG
See all newsBrief: CRISPR Therapeutics Announces Chief Financial Officer Transition
Swiss stocks - Factors to watch on August 4
Switzerland's CRISPR Therapeutics Q2 CASGEVY revenue jumps 151%, net loss narrows on FDA approval for expansion
Swiss stocks - Factors to watch on August 3
Gene-editing firm CRISPR steadies after boosted $550 mln convertible debt deal